ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $39,000 | -20.4% | 798 | -31.4% | 0.00% | 0.0% |
Q4 2020 | $49,000 | +19.5% | 1,164 | +29.0% | 0.00% | 0.0% |
Q3 2020 | $41,000 | -86.8% | 902 | -82.6% | 0.00% | -85.7% |
Q3 2019 | $311,000 | -6.3% | 5,170 | +31.4% | 0.01% | -12.5% |
Q2 2019 | $332,000 | +44.3% | 3,936 | +46.2% | 0.01% | -11.1% |
Q3 2018 | $230,000 | +784.6% | 2,693 | +498.4% | 0.01% | +350.0% |
Q4 2017 | $26,000 | – | 450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |